Compare ARK Genomic Revolution ETF (ARKG) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares 0 3 Month Treasury Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while iShares 0 3 Month Treasury Bond ETF trades at $100.52. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares 0 3 Month Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | SGOV | |
|---|---|---|
Sector | Sector/Thematic | Fixed Income |
52-Week High | $43.57 | $100.74 |
52-Week Low | $23.09 | $100.28 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SGOV, the iShares 0-3 Month Treasury Bond ETF, trades at $100.50, showing minimal daily movement with a 0.02% gain. Technical indicators signal a bearish trend from moving averages, though oscillators are neutral. The ETF functions as a cash management vehicle, holding ultra-short-term U.S. Treasury bills, with key financial ratios like P/E and P/B not applicable due to its structure. Recent news highlights strong investor inflows into short-term bond ETFs amid rate uncertainty.
The outlook for SGOV remains stable, offering a low-risk haven for cash with yields around 3.5–3.6%, appealing in volatile markets. Risks include potential Fed rate hikes reducing relative yield appeal and inflation eroding returns. Analyst sentiment is positive for its role in agile, income-focused portfolios, but investors should weigh opportunity costs against equity investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
